Diselenide Covalent Allosteric Inhibitors of Glutaminase with Strong <i>In Vivo</i> Anticancer Activity-Reference-Cited by-同舟云学术

Diselenide Covalent Allosteric Inhibitors of Glutaminase with Strong In Vivo Anticancer Activity

Published:2023-05-03 Issue:7 Volume:14 Page:920-928
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Hou Wei¹^ORCID,Chen Zhao¹,Pan Chuqiao¹,Ni Maowei²,Ruan Haoqiang¹,Song Jun¹,Lu Shiying¹,Bhasin Aman³,Ruan Benfang Helen¹^ORCID

Affiliation:

1. College of Pharmaceutical Science, Collaborative Innovation Center of Yangtza River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, China

2. Center for Cancer Research, Zhejiang Cancer Hospital, Hangzhou 310022, China

3. Amity School of Chemical Sciences, Amity University, Panjab, Sector 82A, Mohali-140306, India

Funder

Natural Science Foundation of Zhejiang Province

Fuyang government

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.2c00470

Reference17 articles.

1. From Krebs to clinic: glutamine metabolism to cancer therapy

2. A tale of two glutaminases: homologous enzymes with distinct roles in tumorigenesis

3. Targeting glutamine metabolism network for the treatment of therapy-resistant prostate cancer

4. Recent Progress in the Discovery of Allosteric Inhibitors of Kidney-Type Glutaminase

5. The EZMTT cell proliferation assay provides precise measurement for drug combinations and better correlation between in vitro and in vivo efficacy

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Psammaplin A analogues with modified disulfide bond targeting histone deacetylases: Synthesis and biological evaluation;European Journal of Medicinal Chemistry;2024-09